Immediate Impact
1 from Science/Nature 24 standout
Citing Papers
Multidrug-resistant tuberculosis
2024 Standout
Drug-resistant tuberculosis: a persistent global health concern
2024 Standout
Works of Jonathan Stillo being referenced
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?
2017
Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jonathan Stillo | 192 | 140 | 67 | 15 | 236 | |
| Erica Lessem | 168 | 123 | 51 | 13 | 215 | |
| Tomàs Maria Pérez-Porcuna | 182 | 148 | 67 | 23 | 262 | |
| David Mametja | 204 | 157 | 60 | 9 | 248 | |
| Maryse Wanlin | 223 | 178 | 107 | 13 | 275 | |
| Bazarragchaa Tsogt | 191 | 145 | 66 | 8 | 233 | |
| Lindsay McKenna | 176 | 113 | 76 | 23 | 246 | |
| Alberto Roggi | 210 | 158 | 60 | 15 | 297 | |
| E. M. Bogorodskaya | 254 | 158 | 94 | 28 | 292 | |
| Katherine Robsky | 210 | 149 | 80 | 21 | 240 | |
| Jay Achar | 264 | 140 | 72 | 26 | 299 |
All Works
Login with ORCID to disown or claim papers
Loading papers...